Lhotta Karl, Piret Sian E, Kramar Reinhard, Thakker Rajesh V, Sunder-Plassmann Gere, Kotanko Peter
Department of Nephrology and Dialysis, Academic Teaching Hospital Feldkirch, Austria.
Nephron Extra. 2012 Jan;2(1):147-58. doi: 10.1159/000339102. Epub 2012 Jun 1.
BACKGROUND/AIMS: Uromodulin-associated kidney disease (UAKD) is caused by uromodulin mutations and leads to end-stage renal disease. Our objective was to examine the epidemiology of UAKD.
Data from all UAKD families in Austria were collected. Patients included in the Austrian Dialysis and Transplantation Registry (OEDTR) with unclear diagnoses or genetic diseases were asked whether they had (1) a family history of kidney disease or (2) had suffered from gout. Patients with gout and autosomal dominant renal disease underwent mutational analysis. Kaplan-Meier and Cox analysis was employed to estimate time to renal failure.
Of the 6,210 patients in the OEDTR, 541 were approached with a questionnaire; 353 patients answered the questionnaire. Nineteen of them gave two affirmative answers. In 7 patients, an autosomal dominant renal disease was found; in 1 patient a UMOD mutation was identified. One family was diagnosed through increased awareness as a consequence of the study. At present, 14 UAKD patients from 5 families are living in Austria (1.67 cases per million), and 6 of them require renal replacement therapy (0.73 per 1,000 patients). Progression to renal failure was significantly associated with UMOD genotype.
UAKD patients can be identified by a simple questionnaire. UMOD genotype may affect disease progression.
背景/目的:尿调节蛋白相关肾病(UAKD)由尿调节蛋白突变引起,可导致终末期肾病。我们的目的是研究UAKD的流行病学情况。
收集了奥地利所有UAKD家族的数据。奥地利透析与移植登记处(OEDTR)中诊断不明或患有遗传性疾病的患者被询问是否有(1)肾病家族史或(2)患过痛风。对患有痛风和常染色体显性遗传性肾病的患者进行突变分析。采用Kaplan-Meier法和Cox分析法评估肾衰竭时间。
在OEDTR的6210名患者中,541人收到了调查问卷;353名患者回答了问卷。其中19人给出了两个肯定回答。在7名患者中发现了常染色体显性遗传性肾病;在1名患者中鉴定出UMOD突变。通过该研究提高了认识,从而诊断出一个家族。目前,奥地利有来自5个家族的14名UAKD患者(每百万人口中有1.67例),其中6人需要肾脏替代治疗(每1000名患者中有0.73例)。肾衰竭进展与UMOD基因型显著相关。
通过简单的问卷即可识别UAKD患者。UMOD基因型可能影响疾病进展。